Market Research Logo

Iraq Pharmaceuticals and Healthcare Report Q2 2016

Iraq Pharmaceuticals and Healthcare Report Q2 2016

BMI View: With lower revenues from oil exports and significant costs associated with the battle againstIslamic State, the Iraqi government will continue to face headwinds in providing healthcare to itspopulation. Furthermore, economic headwinds will also feed through to consumer spending, deterringinvestment in adequate access to healthcare and medicines, which in turn will weigh on a more significantmarket recovery. However, strong demand for healthcare will continue to translate to pharmaceuticals andhealthcare sector growth over the forecast period.

Headline Expenditure Projections

Pharmaceuticals: IQD2.02trn (USD1.71bn) in 2015 to IQD2.19trn (USD1.71bn) in 2016; +8.2% inlocal currency and +0.2% in US dollar terms. Forecast broadly in line with last quarter.

Healthcare: IQD11.77trn (USD9.96bn) in 2015 to IQD12.54trn (USD9.83bn) in 2016; +6.6% in localcurrency and -1.3% in US dollar terms. Forecast revised downwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Iraq 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Iraq 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Iraq 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Iraq 2012
2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Iraq 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Iraq 2014
2020)
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index Q2 2016
Iraq Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Regime
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Iraq 2010
2015)
Table: Healthcare Personnel (Iraq 2010
2015)
Table: Healthcare Activity (Iraq 2010
2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
ResearchBased Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Samarra
Ninewa
Awamedica
Demographic Forecast
Table: Population Headline Indicators (Iraq 1990
2025)
Table: Key Population Ratios (Iraq 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Iraq 1990
2025)
Table: Population By Age Group (Iraq 1990
2025)
Table: Population By Age Group % (Iraq 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report